Litcius/Paper detail

Sirolimus-based immunosuppression improves the prognosis of liver Transplantation Recipients with low TSC1/2 expression in hepatocellular carcinoma beyond the Milan Criteria

Qianwei Ye, Sunbin Ling, Guangjiang Jiang, Qiaonan Shan, Shengjun Xu, Qifan Zhan, Yifeng Wu, Yuchen Liu, Shusen Zheng, Xiao Xu

2021European Journal of Surgical Oncology16 citationsDOI

Topics & Concepts

TSC1SirolimusImmunosuppressionLiver transplantationHepatocellular carcinomaMedicineTuberous sclerosisEverolimusImmunohistochemistryTransplantationMilan criteriaTSC2PI3K/AKT/mTOR pathwayInternal medicineGastroenterologyCancer researchPathologyBiologyApoptosisBiochemistryTuberous Sclerosis Complex ResearchPI3K/AKT/mTOR signaling in cancerPolyomavirus and related diseases
Sirolimus-based immunosuppression improves the prognosis of liver Transplantation Recipients with low TSC1/2 expression in hepatocellular carcinoma beyond the Milan Criteria | Litcius